Improved relapse-free survival in medulloblastoma utilizing modern techniques

Area of Science:

• Pediatric Oncology
• Neurosurgery
• Radiation Oncology

Background:

• Medulloblastoma treatment historically faced challenges in achieving optimal outcomes.
• Surgical and diagnostic advancements can significantly impact patient survival rates.

Purpose of the Study:

• To evaluate the impact of new surgical and diagnostic technologies on medulloblastoma treatment outcomes.
• To compare relapse-free survival rates before and after the introduction of computed tomographic (CT) scanning and operating microscopes.

Main Methods:

• A cohort of 22 medulloblastoma patients was divided into two groups (1969-1974 and 1974-1979).
• Group 1 (n=11) received treatment prior to CT scanner and operating microscope availability.
• Group 2 (n=11) received treatment after the introduction of these technologies, with identical radiation doses and surgical goals.

Main Results:

• Relapse-free survival at 4 years was 38% for Group 1 and 84% for Group 2.
• The observed improvement in survival was statistically significant (P <= 0.001).
• Total surgical resection did not increase postoperative morbidity or mortality.

Conclusions:

• The introduction of computed tomographic (CT) scanning and operating microscopes significantly improved medulloblastoma treatment outcomes.
• Technological advancements, including enhanced surgical resection and focused radiation therapy, are critical for improving survival.
• Optimized surgical techniques and diagnostic tools contribute to better patient prognoses in pediatric brain tumor treatment.